As a result, crucial changes in the 2020 European Association of Urology (EAU) guidelines were established, promoting mpMRI to being recommended initially for every patient with suspicion of PCa (elevated PSA/abnormal DRE) before performing the biopsy14. This evidence concerns the gene KLK3 and posterior cortical atrophy.